Blood taken

PreclinicalBiologic

HHospices Civils de Lyon

Blood taken is one of 158 biologic programs targeting Metastatic Melanoma. It is currently in Preclinical.

Indications

Total Trials

Active Trials

157

Competitors

Pipeline

Status by Indication[3][1]

Indication

Metastatic MelanomaActive, not recruiting

SepsisActive, not recruiting

Chronic Lymphocytic LeukemiaActive, not recruiting

Atrial FibrillationActive, not recruiting

COVID-19Active, not recruiting

Metastatic MelanomaPreclinical

Active, not recruiting

SepsisPreclinical

Active, not recruiting

Chronic Lymphocytic LeukemiaPreclinical

Active, not recruiting

Atrial FibrillationPreclinical

Active, not recruiting

COVID-19Preclinical

Active, not recruiting

Competition

Competitive Landscape

1931 competitors in COVID-19

#DrugCompanyPhaseTrials

Spikevax

Moderna

Preclinical

21 2

Bnt162b2

BioNTech

Preclinical

29 3

Aldactone

Pfizer

Preclinical

1 4

Nexavar

Bayer

Preclinical

1 5

Low-Molecular-Weight Heparin

Daiichi Sankyo

Preclinical

3 6

SARS-COV-2 VACCINE

Moderna

Preclinical

2 7

Glucocorticoid

AbbVie

Preclinical

1 8

Statins

Sanofi

Preclinical

1 9

HB-Admscs

HHope Biosciences Research Foundation

Preclinical

4 10

Blood taken

HHospices Civils de Lyon

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2028

N/ARecruiting

HHT

NCT07111598

Q2 2029

Recruiting

Atrial Fibrillation

NCT03611816

Q4 2033

Recruiting

Brain Tumors

NCT05571579

Clinical

Trials by Indication[1]

Atrial Fibrillation1 trial

Biological Bank for Atrial Fibrillation and Stroke

Recruiting·HHospices Civils de Lyon··NCT03611816·1,000 enrolled

HHT1 trial

Immunological Effects of Iron Supplementation in HHT Disease

Recruiting·HHospices Civils de Lyon·N/A·NCT07111598·155 enrolled

Sepsis1 trial

Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis

Recruiting·HHospices Civils de Lyon··NCT06219135·1,372 enrolled

Chronic Lymphocytic Leukemia1 trial

Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia

Completed·HHospices Civils de Lyon··NCT02520895·98 enrolled

Brain Tumors1 trial

Biological Collection of Brain Tumors

Recruiting·HHospices Civils de Lyon··NCT05571579·500 enrolled

3 more indications

Liver1 trial

Liver Graft Viability Assessment During Normothermic Regional Perfusion

Completed·HHospices Civils de Lyon·N/A·NCT05361044·60 enrolled

COVID-191 trial

TIXAGEVIMAB/CILGAVIMAB Protection of Covid-19 in Transplanted Patients

Withdrawn·HHospices Civils de Lyon··NCT05234398

Metastatic Melanoma1 trial

Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma

Completed·HHospices Civils de Lyon·N/A·NCT03225365·5 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Blood taken. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Blood taken compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Blood taken. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hospices Civils de Lyon company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: HHospices Civils de Lyon

Blood taken

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2028

Q2 2029

Q4 2033

Trials by Indication[1]

Atrial Fibrillation1 trial

HHT1 trial

Sepsis1 trial

Chronic Lymphocytic Leukemia1 trial

Brain Tumors1 trial

Liver1 trial

COVID-191 trial

Metastatic Melanoma1 trial

References

Drug Info

Quick Facts

Related News